Jiangsu Hengrui ribupatide injection marketing application accepted in China
Jiangsu Hengrui Pharmaceuticals Co Ltd said its ribupatide injection marketing application was accepted by China’s drug regulator.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.